← Back
Data updated: Mar 29, 2026
EMERGENT
Infectious Disease
Pharma
EMERGENT is a pharmaceutical company focused on Infectious Disease.
2008
Since
2
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
0 drugs Phase 1: 8
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2008-01-23
- Latest
- 2026-02-11
- Applications
- 2